Methylated ctDNA quantification: non-invasive approach to monitoring hepatocellular carcinoma burden

I Angeli-Pahim, A Chambers, S Duarte… - Journal of the …, 2023 - journals.lww.com
Background: Non-invasive, precision monitoring of hepatocellular carcinoma (HCC)
treatment efficacy would greatly facilitate personalized therapy and improve patient …
被引用次数：1 相关文章

Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden

I Angeli-Pahim, A Chambers… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Noninvasive, precision monitoring of hepatocellular carcinoma (HCC) treatment
efficacy would greatly facilitate personalized therapy and improve patient outcomes. We …

Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden

I Angeli-Pahim, A Chambers, S Duarte… - Journal of the …, 2024 - journals.lww.com
BACKGROUND: Noninvasive, precision monitoring of hepatocellular carcinoma (HCC)
treatment efficacy would greatly facilitate personalized therapy and improve patient …

Methylated ctDNA Quantification: Non-Invasive Approach to Monitoring Hepatocellular Carcinoma Burden.

I Angeli-Pahim, A Chambers, S Duarte… - Journal of the …, 2023 - europepmc.org
Background Non-invasive, precision monitoring of hepatocellular carcinoma (HCC)
treatment efficacy would greatly facilitate personalized therapy and improve patient …